Brief: Theon International Enters Exclusivity Agreement To Buy HGH For €300 Mln Enterprise Value
17/06/2026 19:00
BRIEF-Theon International Enters Exclusivity Agreement To Buy HGH For €300 Mln Enterprise Value June 17 (Reuters) - Theon International Plc THEON.AS:
THEON INTERNATIONAL - ENTERS EXCLUSIVITY AGREEMENT TO BUY HGH FOR €300 MILLION ENTERPRISE VALUE
THEON INTERNATIONAL: DEAL WILL BE FINANCED WITH BRIDGE FACILITY PROVIDED BY BNP PARIBAS, INTENDED TO BE FULLY REFINANCED WITH DEBT
THEON INTERNATIONAL: DEAL EXPECTED TO BE EBITDA MARGIN ACCRETIVE, MID-SINGLE-DIGIT EPS ACCRETIVE IN 2027
Source text: ID:nGNX8c5XV2
Further company coverage: THEON.AS
((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Theon International
See all newsBrief: Theon International Wins Night Vision Contracts Worth EUR 45 Mln From Two European NATO States
Brief: Theon Secures New Orders Of Around €50 Mln To Supply Nyx, Orion Goggles
French and Benelux stocks-Factors to watch
Brief: Theon International Q2 Revenue At €128.6 Mln
Brief: Theon International Enters Exclusivity Agreement To Buy HGH For €300 Mln Enterprise Value